Hourglass Capital LLC Sells 95 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Hourglass Capital LLC reduced its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.4% in the second quarter, HoldingsChannel.com reports. The fund owned 22,707 shares of the company’s stock after selling 95 shares during the quarter. HCA Healthcare accounts for 2.2% of Hourglass Capital LLC’s holdings, making the stock its 12th biggest position. Hourglass Capital LLC’s holdings in HCA Healthcare were worth $7,295,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also bought and sold shares of the company. FinTrust Capital Advisors LLC lifted its holdings in shares of HCA Healthcare by 26.7% in the 4th quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock worth $45,000 after purchasing an additional 35 shares in the last quarter. Financial Counselors Inc. raised its holdings in shares of HCA Healthcare by 1.4% in the 1st quarter. Financial Counselors Inc. now owns 2,642 shares of the company’s stock worth $881,000 after acquiring an additional 36 shares during the last quarter. Premier Path Wealth Partners LLC boosted its stake in HCA Healthcare by 2.7% during the 2nd quarter. Premier Path Wealth Partners LLC now owns 1,393 shares of the company’s stock valued at $448,000 after purchasing an additional 36 shares during the last quarter. Westside Investment Management Inc. raised its stake in shares of HCA Healthcare by 14.7% in the second quarter. Westside Investment Management Inc. now owns 289 shares of the company’s stock worth $93,000 after purchasing an additional 37 shares during the last quarter. Finally, ZWJ Investment Counsel Inc. grew its holdings in HCA Healthcare by 3.5% during the second quarter. ZWJ Investment Counsel Inc. now owns 1,082 shares of the company’s stock worth $348,000 after buying an additional 37 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Trading Up 0.9 %

Shares of HCA opened at $401.36 on Friday. The business’s 50-day moving average price is $354.09 and its 200-day moving average price is $335.48. The stock has a market cap of $105.12 billion, a PE ratio of 19.83, a P/E/G ratio of 1.52 and a beta of 1.68. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $401.87. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. During the same quarter in the prior year, the firm posted $4.29 earnings per share. The business’s quarterly revenue was up 10.3% on a year-over-year basis. On average, equities analysts forecast that HCA Healthcare, Inc. will post 22.5 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a dividend of $0.66 per share. The ex-dividend date is Monday, September 16th. This represents a $2.64 annualized dividend and a yield of 0.66%. HCA Healthcare’s payout ratio is presently 13.16%.

Insider Transactions at HCA Healthcare

In related news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the transaction, the senior vice president now directly owns 9,454 shares in the company, valued at approximately $3,436,623.54. The disclosure for this sale can be found here. Insiders have sold 8,844 shares of company stock valued at $3,185,932 in the last quarter. Insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

HCA has been the topic of a number of analyst reports. Leerink Partners lifted their price objective on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Truist Financial increased their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research report on Monday, August 19th. Deutsche Bank Aktiengesellschaft boosted their price objective on HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a research report on Friday, June 28th. Finally, Royal Bank of Canada boosted their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a report on Friday, August 23rd. Five analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $359.89.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.